FDA plans to name permanent CBER and CDER heads alongside a new commissioner; Overton, Vacirca and Ferrara emerge as top nominee contenders.
The FDA is planning to announce a slate of senior personnel announcements when a new commissioner is named, including permanent heads of CBER and CDER …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
The FDA has narrowed its search for a new leader of its Center for Biologics Evaluation and Research to three to four final…
The agency may not have permanent leadership until after the midterms, says one expert
With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at…
Marty Makary's resignation leaves the agency with temporary directors in three top positions, and a number of newly instituted…
With the FDA now rudderless following the revelation that commissioner Marty Makary, M.D., is stepping down, voices across…
Vijay Kumar, FDA's acting OTP director, says he's stepping down for reasons unrelated to agency turmoil, as the White House also…
